These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28744101)

  • 21. Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.
    Di Costanzo GG; Lanza AG; Picciotto FP; Imparato M; Migliaccio C; De Luca M; Scuderi V; Tortora R; Cordone G; Utech W; Calise F
    Am J Transplant; 2013 Feb; 13(2):348-52. PubMed ID: 23137160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.
    Fernández I; Loinaz C; Hernández O; Abradelo M; Manrique A; Calvo J; Manzano M; García A; Cambra F; Castellano G; Jiménez C
    Transpl Infect Dis; 2015 Oct; 17(5):695-701. PubMed ID: 26257166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
    Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y
    Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Radhakrishnan K; Chi A; Quan DJ; Roberts JP; Terrault NA
    Transplantation; 2017 Sep; 101(9):2079-2082. PubMed ID: 28880197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection.
    Partovi N; Guy MW; Ensom MH; Noble MA; Yoshida EM
    Am J Transplant; 2001 May; 1(1):51-4. PubMed ID: 12095038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.
    Angus PW; Patterson SJ; Strasser SI; McCaughan GW; Gane E
    Hepatology; 2008 Nov; 48(5):1460-6. PubMed ID: 18925641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence.
    Powell JJ; Apiratpracha W; Partovi N; Erb SR; Scudamore CH; Steinbrecher UP; Buczkowski AK; Chung SW; Yoshida EM
    Clin Transplant; 2006; 20(4):524-5. PubMed ID: 16842532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.
    Singham J; Greanya ED; Lau K; Erb SR; Partovi N; Yoshida EM
    Ann Hepatol; 2010; 9(2):166-71. PubMed ID: 20526010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation.
    Nymann T; Shokouh-Amiri MH; Vera SR; Riely CA; Alloway RR; Gaber AO
    Clin Transplant; 1996 Dec; 10(6 Pt 2):663-7. PubMed ID: 8996762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.
    Adler R; Safadi R; Caraco Y; Rowe M; Etzioni A; Ashur Y; Shouval D
    Hepatology; 1999 Apr; 29(4):1299-305. PubMed ID: 10094978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
    Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
    World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoeconomic analysis of HBV liver transplant therapies.
    McGory R
    Clin Transplant; 2000; 14 Suppl 2():29-38. PubMed ID: 10965962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
    Kwon CH; Suh KS; Yi NJ; Chang SH; Cho YB; Cho JY; Lee HJ; Seo JK; Lee KU
    Pediatr Transplant; 2006 Jun; 10(4):479-86. PubMed ID: 16712607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
    Chen G; Liu H; Hu ZQ; Bai JH; Liu QY; Zhao YP; Gan XM; Wang F; Wang DD; Ma LJ; Li L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):901-6. PubMed ID: 26011237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy.
    Nath DS; Kalis A; Nelson S; Payne WD; Lake JR; Humar A
    Clin Transplant; 2006; 20(2):206-10. PubMed ID: 16640528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
    Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatitis B recurrence after liver transplantation: efficacy and safety of intramuscular anti-hepatitis B immunoglobulins].
    Marzano A
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1 Suppl 1):1-17. PubMed ID: 23570102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis against recurrence of HBV hepatitis after living-donor liver transplantation.
    Tashiro H; Itamoto T; Fudaba Y; Ohdan H; Fukuda S; Kohashi T; Amano H; Ishiyama K; Ide K; Ogawa T; Shishida M; Irei T; Ushitora Y; Ohira M; Takahashi S; Chayama K; Asahara T
    Hepatogastroenterology; 2008; 55(86-87):1746-9. PubMed ID: 19102383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.